Biologos

Executive Summary

Biologos is a well-established US-based GMP manufacturer of custom cell culture media, buffers, and reagents, serving the biologics industry since 1976. With ISO 13485:2016 certification, the company supports cell & gene therapy, biopharma, and diagnostics from pilot to commercial scale. Its state-of-the-art facility in Grand Rapids, Michigan, positions it as a reliable supplier for critical raw materials. As the biologics market grows, driven by advances in cell and gene therapies, Biologos stands to benefit from increasing demand for high-quality, custom-formulated media and buffers. The company's long history and compliance with rigorous quality standards provide a competitive edge over newer entrants. However, its private status and limited public visibility suggest a conservative growth trajectory, with potential for expansion through capacity additions or strategic partnerships.

Upcoming Catalysts (preview)

• Q4 2026Manufacturing Capacity Expansion60% success
• Q2 2027Key Partnership with Cell/Gene Therapy Developer50% success
• Q3 2026New Product Launch for Emerging Biologics Modalities70% success